ACCRU-BR-1801

A Phase II Trial of Abemaciclib and T-DM1 in Women and Men with HER2 positive Advanced or Metastatic Breast Cancer Who Progressed on Treatment with a Taxane, Trastuzumab and Pertuzumab https://clinicaltrials.gov/ct2/show/NCT04351230?term=NCT04351230&draw=2&rank=1
Contact email
cancerclinicaltrials@sparrow.org
Principal investigator
Gordan Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Breast
Webform